Name: Covilife (Ivermectin) Uses, Dosage, Benefits & Side Effects
Availability: InStock

Covilife (Ivermectin) | Clinically Trusted Broad-Spectrum Antiparasitic Medicine

Product Overview

Covilife Tablet is a clinically established, broad-spectrum oral antiparasitic medication formulated with Ivermectin as its active pharmaceutical ingredient, available in high-strength formulations of 24mg and 40mg designed to meet the dosing requirements of specific parasitic infections in adult patients under physician supervision.

Ivermectin — the scientifically validated active compound in Covilife — belongs to the prestigious avermectin class of antiparasitic agents, a drug family whose discovery earned its inventors the 2015 Nobel Prize in Physiology or Medicine. It works by selectively binding to glutamate-gated chloride ion channels found exclusively in the nervous and muscular tissues of invertebrate parasites, causing irreversible paralysis and death of susceptible organisms while leaving human cells unaffected.

Healthcare professionals prescribe Covilife Tablet for the treatment of a range of clinically significant parasitic infections, including strongyloidiasis (intestinal threadworm), onchocerciasis (river blindness), scabies, head lice, and other susceptible parasitic conditions. The higher strength formulations available in Covilife accommodate the weight-based dosing requirements of larger adult patients or specific therapeutic protocols prescribed under medical supervision.

Ivermectin is listed on the World Health Organization’s Model List of Essential Medicines, and its decades-long track record of global clinical use affirms Covilife as a trusted antiparasitic tablet choice for physician-directed therapy.

⚠️ Important Notice: Covilife Tablet is indicated exclusively for the treatment of approved parasitic infections as determined by a qualified healthcare professional. All use must be based on proper diagnosis, appropriate weight-based dosing, and ongoing professional supervision. This product page does not support or promote any use of Ivermectin for non-approved, non-parasitic, or investigational indications.

What Is Covilife Tablet?

Covilife Tablet is an oral antiparasitic medicine containing Ivermectin as its active moiety, formulated in 24mg and 40mg strengths to enable accurate, weight-appropriate dosing for adult patients with confirmed parasitic infections requiring higher-dose therapeutic regimens under the direction of a licensed physician.

Ivermectin has been in clinical use in human medicine since the early 1980s and has accumulated one of the most extensive and well-characterized safety and efficacy profiles in antiparasitic pharmacology. The co-discoverers of this remarkable compound — Japanese microbiologist Satoshi Ōmura and Irish parasitologist William C. Campbell — were jointly awarded the Nobel Prize in Physiology or Medicine in 2015 in recognition of Ivermectin’s transformative impact on global parasitic disease control. This scientific recognition underscores the exceptional credibility and clinical value of the active ingredient present in every Covilife Tablet.

The higher-strength formulations of Covilife — 24mg and 40mg — reflect the weight-based nature of Ivermectin dosing, where the standard therapeutic dose for most parasitic indications is 150 to 200 micrograms per kilogram of body weight (mcg/kg). For adult patients with higher body weights, or for specific clinical protocols requiring higher individual doses, these strengths allow accurate dosing without requiring patients to take multiple lower-strength tablets simultaneously.

Covilife Tablet is suitable for adults and children meeting the minimum weight threshold of 15 kg (33 lbs), as prescribed by a qualified physician following a confirmed diagnosis. It must not be used for self-medication or for conditions that have not been clinically confirmed as susceptible to Ivermectin therapy.

Active Ingredient: Ivermectin

Each Covilife Tablet delivers a precisely measured dose of Ivermectin — either 24mg or 40mg — formulated with pharmaceutical-grade excipients selected to ensure tablet stability, consistent dissolution, and predictable bioavailability across patient populations.

Ivermectin is a semi-synthetic avermectin derivative derived from the fermentation of the soil bacterium Streptomyces avermitilis. It is a highly lipophilic compound — meaning it distributes extensively into fatty tissues throughout the body — which enables it to reach ectoparasites residing within skin layers and subcutaneous tissues, as well as endoparasites colonizing the intestinal mucosa and lymphatic system.

Following oral administration, Ivermectin is absorbed through the gastrointestinal tract and achieves peak plasma concentrations approximately four to five hours after ingestion. It has a plasma half-life of approximately 12 to 36 hours, enabling sustained antiparasitic action from a single or short-course dose. The drug is extensively metabolized in the liver primarily via CYP3A4 enzymatic pathways, with metabolites excreted predominantly in the feces.

Mechanism of Action

Ivermectin exerts its potent antiparasitic action through a highly selective, precisely characterized molecular mechanism:

The drug binds with exceptional affinity and selectivity to glutamate-gated chloride ion channels (GluCl channels) — ligand-gated ion channels found exclusively in the peripheral nerve and muscle cells of invertebrate organisms including nematodes, arthropods, and insect vectors. These channels play a fundamental role in the invertebrate nervous system by regulating membrane permeability to chloride ions.

Upon Ivermectin binding, GluCl channels undergo a conformational change that causes a sustained, irreversible influx of chloride ions into parasite nerve and muscle cells. This chloride influx results in:

Persistent hyperpolarization of the cell membrane — making it impossible for the parasite’s nerve cells to generate or transmit normal electrical impulses
Irreversible flaccid paralysis of the parasite’s musculature — eliminating the ability to move, feed, burrow, or maintain positional attachment to host tissue
Cessation of pharyngeal pumping — the mechanism parasites use to ingest nutrients from their host
Suppression of reproductive activity — inhibiting microfilariae production and larval development, breaking the parasite transmission cycle

The critical safety advantage of Ivermectin in human patients rests on two protective physiological mechanisms:

Human cells do not express glutamate-gated chloride channels — Ivermectin therefore has no primary molecular target in human neurological tissue
The intact human blood-brain barrier prevents Ivermectin from accessing GABA-gated chloride channels in the central nervous system at therapeutic doses, where otherwise potential interactions could occur

This dual protective mechanism explains why Ivermectin achieves potent antiparasitic action at therapeutic doses without causing neurological or muscular toxicity in human patients with intact blood-brain barrier function.

Why Prompt Treatment of Parasitic Infections Matters

Parasitic infections are frequently underdiagnosed due to their often insidious onset and non-specific initial symptoms. Many patients attribute early signs of infection — such as intermittent abdominal discomfort, unexplained fatigue, or mild skin changes — to more common conditions. This diagnostic delay allows parasitic infections to progress, sometimes to stages with significantly more serious clinical consequences:

Strongyloidiasis can evolve into life-threatening hyperinfection syndrome or disseminated strongyloidiasis in immunocompromised individuals, with larvae migrating to the lungs, liver, heart, and brain — a condition with a case fatality rate exceeding 80% if untreated
Onchocerciasis causes progressive, irreversible corneal inflammation leading to permanent visual loss and blindness through the accumulation of inflammatory responses to dying microfilariae
Crusted (Norwegian) scabies — a severe hyperinfestation involving millions of mites — can develop in immunocompromised patients, causing extensive crusted skin lesions and posing a high transmission risk to close contacts
Chronic parasitic infections progressively deplete nutritional reserves, suppress immune function, contribute to anemia, and significantly reduce quality of life

Early diagnosis and prompt treatment with a trusted Ivermectin medicine like Covilife Tablet interrupts these harmful disease progressions and initiates rapid, clinically meaningful recovery.

The Global Burden of Parasitic Disease

The worldwide prevalence of parasitic infections addressed by Ivermectin therapy is staggering:

Strongyloidiasis is estimated to affect between 370 and 600 million people globally — many of them undiagnosed
Onchocerciasis affects approximately 21 million people, with over one million experiencing visual impairment or blindness
Scabies infests approximately 200 million people at any given time globally, with much higher prevalence in tropical and resource-limited settings
Lymphatic filariasis (a filarial infection also addressed in combination programs involving Ivermectin) threatens over 850 million people in 50 endemic countries

Access to effective, physician-directed antiparasitic therapy — including Covilife Ivermectin Tablet — represents a critical element of both individual healthcare and global public health disease control strategy.

Uses of Covilife Tablet

Covilife Tablet (Ivermectin 24mg / 40mg) is indicated for the treatment of specific parasitic infections in adult patients under physician supervision. The high-strength formulations available in Covilife provide accurate, weight-appropriate dosing for a range of approved therapeutic applications.

📋 Clinical Note: All uses of Covilife Tablet must be based on a confirmed parasitic diagnosis by a qualified healthcare professional. The strengths available (24mg and 40mg) are prescribed according to individual patient weight and the specific infection being treated. Self-medication is not appropriate for any Ivermectin indication.

🔹 Strongyloidiasis (Intestinal Threadworm Infection)

Strongyloidiasis — caused by the intestinal nematode Strongyloides stercoralis — represents one of the primary and most important clinical indications for Covilife Ivermectin Tablet. This parasitic infection possesses a uniquely dangerous characteristic among intestinal helminths: the capacity for autoinfection, whereby infective larvae re-penetrate the intestinal mucosa or perianal skin without requiring external re-exposure, perpetuating the infection indefinitely within the host.

In immunocompetent individuals, chronic strongyloidiasis typically presents with intermittent gastrointestinal symptoms, urticarial skin rash (larva currens), and pulmonary symptoms during larval migration. However, when host immunity is compromised — by corticosteroid therapy, cancer chemotherapy, HIV infection, organ transplantation, or malnutrition — the autoinfection cycle can amplify dramatically into hyperinfection syndrome, where massive numbers of larvae penetrate the intestinal wall and disseminate to organs throughout the body, carrying bacteria with them and causing potentially fatal septicemia.

Ivermectin is the WHO-recommended first-line treatment for strongyloidiasis, demonstrating consistently superior cure rates compared to benzimidazole alternatives in randomized controlled trials. Covilife Tablet’s higher-strength formulations (24mg and 40mg) facilitate accurate single-dose delivery for adult patients requiring doses that would otherwise necessitate multiple lower-strength tablets.

🔹 Onchocerciasis (River Blindness)

Onchocerciasis — caused by the filarial nematode Onchocerca volvulus, transmitted by the bite of Simulium blackflies breeding in fast-flowing rivers — is the world’s second leading infectious cause of preventable blindness, predominantly affecting populations in sub-Saharan Africa with smaller endemic foci in Yemen and Latin America.

The clinical disease of onchocerciasis is driven not by the adult worms themselves, but by the intense and progressive inflammatory response to microfilariae (microscopic larval worms) dying within the skin, eyes, and other tissues. Chronic microfilarial death in the cornea leads to sclerosing keratitis, while posterior segment involvement can cause optic nerve atrophy and irreversible blindness.

Ivermectin is the cornerstone of the WHO African Programme for Onchocerciasis Control (APOC) and its successor programs — one of the most successful international public health initiatives in history. By killing microfilariae and transiently suppressing their production by adult worms, Ivermectin dramatically reduces the inflammatory burden that drives ocular and dermatological disease progression. Treatment is administered annually or semi-annually in endemic communities as part of systematic control efforts.

For individual patients diagnosed with onchocerciasis outside of mass drug administration programs, physician-prescribed Covilife Ivermectin provides the same therapeutic action — reducing microfilarial skin loads, alleviating itching and dermatological symptoms, and protecting against progressive visual damage.

🔹 Scabies (When Prescribed)

Scabies — caused by the ectoparasitic mite Sarcoptes scabiei var. hominis — is a highly contagious skin infestation characterized by intense generalized pruritus (itching), worse at night, with a characteristic burrow rash affecting the finger webs, wrists, axillae, waistline, and genitalia. Secondary bacterial superinfection from repeated scratching is common and can lead to impetigo or more serious skin infections.

Oral Ivermectin (Covilife Tablet) is an established treatment for scabies, offering particular clinical advantages in specific situations:

Crusted (Norwegian) scabies — a severe hyperinfestation involving millions of mites in patients with impaired cellular immunity, where topical treatments alone are insufficient
Widespread classical scabies where whole-body topical application is impractical or poorly tolerated
Institutional outbreak management in care homes, hospitals, prisons, or school settings, where the simultaneous treatment of large numbers of individuals with oral therapy is logistically superior
Cases where first-line topical therapy has failed or where patient compliance with topical treatment is problematic

The higher-strength formulations in Covilife allow precise weight-based dosing in adult patients, typically requiring a repeat dose one to two weeks after the initial treatment to address newly hatched mites not killed by the first dose.

🔹 Head Lice — Pediculosis Capitis (When Prescribed)

Head louse infestation — caused by Pediculus humanus capitis — affects millions of people worldwide, predominantly school-age children and their household contacts. While primarily managed with topical pediculicidal treatments, oral Ivermectin has demonstrated efficacy for head lice in clinical trials and is increasingly used where:

Topical treatments have repeatedly failed to achieve eradication
Insecticide-resistant lice are suspected or confirmed
Multiple concurrent infestations within a household or institution require a comprehensive systemic treatment approach

Oral Ivermectin reaches lice through the bloodstream when they feed on the scalp, providing a systemic antiparasitic action that topical treatments cannot replicate. Physician guidance is essential for appropriate indication and dosing.

🔹 Other Susceptible Parasitic Infections

Under the direct supervision of a qualified physician and based on confirmed diagnosis and clinical evidence, Covilife Ivermectin may additionally be considered for:

Lymphatic filariasis — In WHO mass drug administration combination regimens with albendazole and/or diethylcarbamazine for control of Wuchereria bancrofti, Brugia malayi, and Brugia timori
Cutaneous larva migrans — Migrating hookworm larvae creating serpiginous tracks beneath the skin
Gnathostomiasis — Tissue-invasive nematode infection in Southeast Asia and other endemic regions
Mansonellosis — Infection caused by Mansonella ozzardi
Intestinal capillariasis — Under specialist guidance where appropriate

⚠️ Evidence and Approval Notice: Covilife Tablet should only be used for clinically established, evidence-based antiparasitic indications as prescribed by a licensed healthcare professional. This product is not approved for, and this page does not in any way promote its use for, viral infections, inflammatory conditions, or any other indication lacking robust regulatory approval and clinical evidence. Patients seeking treatment for any condition must consult a qualified physician for proper diagnosis and prescription.

Benefits of Covilife Tablet

When prescribed appropriately by a healthcare professional for a confirmed parasitic infection, Covilife Tablet (Ivermectin) delivers a range of clinically meaningful therapeutic benefits:

✅ Potent and Targeted Parasite Elimination

Ivermectin’s highly selective binding to invertebrate glutamate-gated chloride channels delivers irreversible neuromuscular paralysis and death of susceptible parasites. Clinical evidence accumulated over four decades confirms high cure rates for strongyloidiasis and significant, sustained microfilarial clearance in onchocerciasis — establishing Covilife as a reliable and effective antiparasitic treatment when used as clinically indicated.

✅ Meaningful Relief from Infection-Related Symptoms

Once parasitic elimination begins following Covilife treatment, patients progressively experience significant improvement in the distressing symptoms that parasitic infections cause:

Substantial reduction in generalized or skin-specific pruritus (itching)
Resolution of dermatological manifestations — burrow rash, papular eruptions, larva currens skin changes
Improvement in gastrointestinal symptoms — cramping, bloating, diarrhea, and nausea
Recovery of normal energy levels and resolution of infection-related fatigue
Protection of visual function by reducing the inflammatory burden of microfilarial death in onchocerciasis

✅ Convenient Single-Dose or Short-Course Oral Administration

Covilife Tablet provides comprehensive systemic antiparasitic action through a single oral dose for most indications — a significant practical advantage over topical antiparasitic treatments that require whole-body application, environmental decontamination protocols, and repeated applications over days or weeks. For infections requiring retreatment (such as scabies), the short, well-defined repeat-dose schedule maintains simplicity while ensuring thorough parasite elimination.

✅ Accurate Weight-Based Dosing Through Higher Strengths

The 24mg and 40mg formulations available in Covilife Tablet address a genuine clinical need: the ability to achieve precise, weight-appropriate dosing for adult patients without requiring the simultaneous administration of multiple lower-strength tablets. This reduces pill burden, improves convenience, and supports accurate dosing compliance — all of which contribute to better treatment outcomes.

✅ Proven Four-Decade Clinical Track Record

Ivermectin — the active ingredient in Covilife — has been used in human medicine since the 1980s, with a clinical evidence base spanning hundreds of randomized controlled trials, systematic reviews, and real-world pharmacovigilance data across millions of treated patients globally. Its Nobel Prize-recognized discovery and its inclusion on the WHO Model List of Essential Medicines reflect an unparalleled standard of scientific validation and global clinical confidence.

✅ Restored Quality of Life After Treatment

The health burden of untreated parasitic infections — including chronic discomfort, sleep disruption from nocturnal itching, nutritional depletion, and the psychological burden of visible skin disease — can profoundly impair daily function and quality of life. Successful treatment with Covilife Ivermectin Tablet restores normal physical comfort, skin health, digestive function, and overall well-being, enabling patients to return fully to their everyday activities and social participation.

How Covilife Tablet Works

Understanding the science behind Covilife Ivermectin’s action empowers patients to appreciate why precise adherence to their physician’s dosing instructions — and completing the full prescribed course — is fundamental to achieving successful treatment.

Step 1 — Oral Ingestion, Absorption, and Systemic Distribution

After swallowing a Covilife Tablet, Ivermectin is absorbed through the gastrointestinal mucosa and enters systemic circulation. Peak plasma concentrations are reached approximately four to five hours after ingestion. Ivermectin’s high lipophilicity (affinity for fatty tissue) enables it to distribute extensively and rapidly throughout body tissues — including the dermis and subcutaneous layers where scabies mites and lice feed, the intestinal mucosa where Strongyloides larvae reside, and the lymphatic and dermal tissues where Onchocerca microfilariae are concentrated.

For most antiparasitic indications, Covilife should be taken on an empty stomach (at least one hour before food or two hours after eating) to ensure predictable, consistent absorption. However, always follow your physician’s specific administration instructions, as guidance may vary by indication.

Step 2 — Selective Binding to Invertebrate GluCl Channels

Once distributed to the site of parasitic infection, Ivermectin molecules bind with high affinity and selectivity to glutamate-gated chloride ion channels (GluCl channels) embedded in the cell membranes of the parasite’s peripheral nerve and muscle cells. These specialized ion channels are present in nematodes, arthropods, and insect vectors — but critically, are absent from human cells — providing the molecular basis for Ivermectin’s selective toxicity against parasites.

Step 3 — Chloride Influx, Hyperpolarization, and Irreversible Paralysis

Ivermectin’s binding to GluCl channels causes a permanent conformational change in the channel protein, resulting in a sustained, irreversible opening of the chloride ion gate. The resulting flood of chloride ions into the parasite’s nerve and muscle cells causes:

Membrane hyperpolarization — the electrochemical gradient across the cell membrane is permanently disrupted
Complete suppression of normal neurotransmission — the parasite cannot generate or respond to nerve impulses
Irreversible flaccid muscular paralysis — total loss of coordinated movement, feeding behavior, and positional maintenance
Cessation of reproductive activity — including microfilariae release in filarial infections, effectively interrupting parasite transmission

Without the ability to feed, move, or reproduce, the parasite rapidly exhausts whatever metabolic reserves remain and dies.

Step 4 — Immune-Mediated Clearance and Natural Elimination

Following parasite immobilization and death, the body’s immune system mobilizes phagocytic cells to engulf and process dead parasite material. In intestinal infections (strongyloidiasis), dead larvae are expelled through normal bowel movements. In skin-based infections (scabies), dead mites are shed as the skin naturally renews itself — explaining why the itching and rash of scabies may persist for two to four weeks after successful treatment as dead mite material is gradually eliminated from the skin. In onchocerciasis, dying microfilariae trigger the Mazzotti inflammatory reaction — a temporary immune response that may cause a brief intensification of itching, fever, and skin reactions, confirming that the medicine is working effectively.

The combination of Ivermectin’s direct antiparasitic action and the body’s subsequent immune clearance results in the comprehensive elimination of the parasitic infection and the progressive resolution of its associated symptoms.

Dosage and Administration

⚠️ Medical Disclaimer: The information below is provided for general educational purposes only. Ivermectin dosing is strictly weight-based and indication-specific. The 24mg and 40mg strengths of Covilife Tablet must only be taken under the explicit prescription and supervision of a qualified and licensed physician. Never self-medicate, adjust doses, or use Ivermectin for conditions not professionally diagnosed as susceptible to Ivermectin therapy.

General Weight-Based Dosage Framework

Ivermectin dosing is calculated according to patient body weight, with the standard therapeutic dose range of 150–200 mcg/kg for most approved indications:

Indication	Standard Dose	Treatment Schedule
Strongyloidiasis	200 mcg/kg body weight	Single dose; repeat after 2 weeks if needed
Onchocerciasis	150 mcg/kg body weight	Single annual dose (or semi-annual per physician)
Classical Scabies	200 mcg/kg body weight	Single dose; repeat dose in 1–2 weeks
Crusted Scabies	200 mcg/kg body weight	Multiple doses per specialist protocol
Head Lice (physician-prescribed)	200–400 mcg/kg body weight	Single dose; repeat in 7–10 days

Your physician will calculate your precise individual dose based on your current body weight and the specific infection being treated.

Selecting the Appropriate Covilife Strength

The 24mg and 40mg formulations of Covilife Tablet are designed to facilitate accurate dosing in adult patients:

A 24mg tablet is appropriate for adult patients in mid-weight ranges where a dose near this level fulfils the 200 mcg/kg prescription
A 40mg tablet provides an accurate dose for heavier adult patients or for specific protocols requiring higher milligram doses

Your physician will specify which strength and how many tablets you should take based on your weight calculation.

How to Take Covilife Tablet Correctly

Take orally with a full glass of water
For most antiparasitic indications, take on an empty stomach — at least one hour before a meal or at least two hours after eating — for consistent absorption
Swallow tablets whole — do not crush, split, or chew unless your physician or pharmacist specifically confirms it is appropriate for your formulation
Take exactly the dose prescribed — neither more nor less — at the specified time
Follow all accompanying physician instructions regarding timing, food restrictions, and any scheduled repeat doses

Missed Dose Guidance

For single-dose regimens: If you did not take your prescribed dose at the intended time, contact your physician or pharmacist for specific guidance before taking the dose late. Do not take a dose significantly out of the planned window without professional advice.

For multi-dose protocols: If a scheduled dose in a multi-dose regimen is missed, take it as soon as you remember on the same day. If the next day has begun, skip the missed dose and continue from the next scheduled dose. Never take a double dose to compensate. Contact your healthcare provider if you are unsure how to proceed.

Overdose Guidance

In the event of accidental or intentional overdose, seek emergency medical attention or contact your nearest Poison Control Centre immediately without delay. Do not wait for symptoms to develop before seeking help. Potential overdose symptoms may include severe dizziness, loss of coordination and balance, intense headache, vomiting, diarrhea, swelling, skin rash, and in serious cases, neurological effects including confusion or altered consciousness.

Completing the Full Prescribed Course

For single-dose treatments, taking the full prescribed dose at the correct time and under correct conditions (fasting, correct body weight calculation) represents complete treatment. For multi-dose or cyclic protocols — including some crusted scabies regimens and repeat-dose schedules — strict adherence to the complete prescribed schedule is essential. Partial treatment may leave sufficient parasites alive to perpetuate infection, particularly in strongyloidiasis where autoinfection can re-establish the parasite burden rapidly.

Possible Side Effects

Covilife Tablet (Ivermectin) is generally well tolerated when taken at the correct weight-based therapeutic dose under physician supervision. Side effects may arise from either the direct pharmacological effects of Ivermectin or — particularly in filarial infections — from the immune-mediated inflammatory response to dying parasites (Mazzotti reaction) rather than from drug toxicity itself.

Commonly Reported Side Effects

🔸 Dizziness — A sensation of lightheadedness or imbalance, typically most pronounced in the first 24 hours following treatment
🔸 Headache — Mild to moderate, generally self-limiting and resolving within one to two days
🔸 Nausea — A temporary feeling of queasiness, particularly if the tablet is taken closer to a meal than recommended
🔸 Diarrhea — Loose stools or increased frequency of bowel movements during the treatment period
🔸 Fatigue — Temporary tiredness or general malaise in the days following treatment, often related to immune response to dying parasites
🔸 Mild abdominal discomfort — Transient stomach cramping or digestive upset

The Mazzotti Reaction (Onchocerciasis and Filarial Infections)

Patients being treated for onchocerciasis and filarial infections with Ivermectin may experience a Mazzotti reaction — a characteristic immune-mediated response to the rapid killing of large numbers of microfilariae. This is not a sign of drug toxicity but rather confirmation of antiparasitic efficacy. Manifestations include:

Fever, chills, and night sweats
Intensification of skin itching and development of urticarial rash
Swelling and tenderness of lymph nodes
Joint and muscle pain
Temporary visual changes
Postural hypotension (dizziness upon standing)

The Mazzotti reaction typically peaks within the first 24 to 48 hours after treatment and resolves within several days. It is generally managed with appropriate anti-inflammatory or antihistamine medications as directed by your physician.

Less Common Side Effects

Peripheral edema in filarial infections (limb or scrotal swelling as inflammatory response to dying filariae)
Temporary visual disturbances or eye irritation
Mild liver enzyme elevations (rare; associated primarily with repeated high-dose use)
Skin rash, urticaria, or pruritus (possible hypersensitivity reaction)

When to Seek Immediate Medical Attention

Seek emergency medical care without delay if you experience any of the following after taking Covilife Tablet:

Severe allergic reaction — sudden swelling of the face, lips, tongue or throat, severe breathing difficulty, or anaphylaxis
Serious neurological symptoms — extreme confusion, loss of balance and coordination, inability to walk, seizures, or altered/loss of consciousness
Severe postural hypotension — extreme dizziness, fainting, or circulatory compromise upon standing
Jaundice — yellowing of the skin or eyes
Severe or worsening skin reactions — extensive blistering, peeling, or pain

Precautions and Warnings

🤰 Pregnancy

Covilife Tablet (Ivermectin) is not recommended during pregnancy, particularly during the first trimester, as comprehensive human reproductive safety data remain limited. Animal studies have demonstrated potential embryotoxic effects at doses exceeding therapeutic levels. In WHO mass drug administration programs for onchocerciasis and lymphatic filariasis, pregnant women are routinely excluded from treatment, with therapy deferred until after delivery. If you are pregnant, planning to become pregnant, or suspect you may be pregnant, inform your physician before taking Covilife Tablet. Your doctor will assess individual clinical circumstances and advise on the safest course of action.

🤱 Breastfeeding

Ivermectin is excreted into breast milk in small quantities, with limited data available on neonatal safety of oral exposure through breastfeeding. Caution is advised for breastfeeding women, and treatment should only proceed after explicit physician assessment of the risk-benefit balance for both mother and infant. For non-urgent indications, some clinical guidelines suggest deferring treatment until breastfeeding has concluded.

🫀 Liver Disease

Covilife Tablet undergoes extensive hepatic metabolism via CYP3A4 pathways. In patients with significant liver impairment (cirrhosis, hepatitis, cholestatic liver disease, or substantially elevated liver enzymes), altered drug metabolism may result in elevated plasma Ivermectin concentrations, potentially increasing both therapeutic exposure and adverse effect risk. Such patients require individualized clinical assessment, potential dose adjustment, and close monitoring throughout treatment. Baseline liver function evaluation may be recommended before initiating therapy in high-risk patients.

🧠 Neurological Disorders and Loa loa Co-infection

The most critical neurological precaution associated with Ivermectin therapy is the risk of severe encephalopathy in patients with very high blood levels of Loa loa microfilariae (typically exceeding 30,000 microfilariae per milliliter). This geographically specific risk is relevant in areas of Central Africa where Loa loa co-exists with onchocerciasis or lymphatic filariasis. Patients in or from these regions must have pre-treatment assessment for Loa loa microfilaremia by a specialist before receiving Ivermectin.

Patients with pre-existing neurological disorders, compromised blood-brain barrier function (such as meningitis or certain inflammatory neurological conditions), or those taking medications that affect CNS function must use Covilife Tablet under close specialist supervision due to potential for increased CNS drug penetration.

⚠️ Allergic Reactions and Hypersensitivity

Do not take Covilife Tablet if you have a confirmed allergy or hypersensitivity to Ivermectin or to any other component of the tablet formulation. A complete allergy and medication history must be taken by your healthcare provider before prescribing Covilife. Report any signs of allergic reaction — including rash, facial swelling, breathing difficulty, or anaphylaxis — to emergency services immediately.

💊 Drug Interactions

Always inform your physician and pharmacist about all medications you are taking before starting Covilife. Key drug interactions include:

Interacting Drug	Interaction	Clinical Significance
Warfarin / Anticoagulants	May potentiate anticoagulant effect	Monitor INR closely during and after treatment
Benzodiazepines	Potential CNS depression enhancement	Use with caution; monitor neurological status
Barbiturates (Phenobarbital)	CYP3A4 induction reduces Ivermectin levels	May reduce therapeutic efficacy
CYP3A4 Inhibitors (Ketoconazole, some HIV antiretrovirals)	Reduced metabolism increases Ivermectin exposure	Risk of elevated plasma levels and adverse effects
Diethylcarbamazine (DEC)	Combination used in filariasis programs	Specialist supervision essential
Strong P-glycoprotein inhibitors	May increase CNS penetration of Ivermectin	Exercise caution — specialist guidance required
Alcohol	May enhance CNS side effects	Avoid alcohol during treatment period

👦 Pediatric Use

Covilife Tablet (24mg and 40mg) is formulated for adult weight-based dosing. For pediatric use, Ivermectin is generally considered appropriate for children weighing 15 kg (33 lbs) or more, dosed at the standard weight-based therapeutic level. Children below 15 kg should not receive Ivermectin without explicit specialist authorization. The 24mg and 40mg strengths of Covilife are primarily intended for adult patients; pediatric dosing typically requires lower-strength formulations to allow accurate dose titration. Always have a qualified pediatrician or specialist confirm the appropriate formulation, strength, and dose for any child patient.

👴 Elderly Patients

Elderly patients frequently present with reduced hepatic metabolic capacity, altered drug distribution, and increased sensitivity to CNS-active agents. While Ivermectin is generally well tolerated in older adults at standard therapeutic doses for short-course treatment, prolonged or repeat-cycle therapy requires close clinical monitoring, including assessment of liver function, neurological status, and cardiovascular response. Covilife Tablet must be used in elderly patients under close physician supervision.

Storage Instructions

Proper storage of Covilife Tablets preserves their full pharmaceutical potency, safety, and shelf life:

🌡️ Store at controlled room temperature below 30°C (86°F)
☀️ Keep away from direct sunlight, excessive heat, and humidity
📦 Store in the original manufacturer-sealed packaging (blister pack or bottle) with the lid or seal securely closed at all times
🚫 Avoid storage in bathrooms, near kitchen sinks, or in any environment subject to steam, condensation, or temperature fluctuations
👶 Keep completely out of reach and sight of children and pets at all times
❌ Never use tablets past their printed expiry date — expired medication may be ineffective and potentially unsafe
🗑️ Dispose of unused or expired tablets through designated pharmaceutical take-back or medicine disposal programs — do not flush down toilets or discard in general household waste

Frequently Asked Questions (FAQs)

❓ What is Covilife Tablet used for?

Covilife Tablet (Ivermectin 24mg / 40mg) is used for the treatment of clinically confirmed parasitic infections under physician prescription. Its primary approved indications include strongyloidiasis (intestinal infection caused by Strongyloides stercoralis), onchocerciasis (river blindness caused by Onchocerca volvulus), scabies (when oral treatment is clinically indicated), and head lice (in cases where topical treatment has failed or oral therapy is prescribed). It is also used in combination with other agents in WHO-coordinated mass drug administration programs for lymphatic filariasis. All use must be based on a confirmed medical diagnosis and physician prescription.

❓ How long does Ivermectin take to work?

Ivermectin begins disrupting parasite neuromuscular function within hours of ingestion. For strongyloidiasis, larval clearance from stool is typically confirmed within two to four weeks of treatment. For scabies, patients often notice a reduction in itching intensity within 48 to 72 hours, though complete skin healing and full resolution of the post-scabies rash may take two to four weeks as dead mite material is naturally shed during skin renewal. For onchocerciasis, microfilarial skin loads begin declining measurably within days of treatment, with ongoing suppression maintained throughout the treatment cycle interval.

❓ Should I take Covilife on an empty stomach?

For most approved antiparasitic indications — including strongyloidiasis and onchocerciasis — Covilife Tablet is recommended to be taken on an empty stomach, specifically at least one hour before eating or two hours after a meal. This approach ensures the most consistent and predictable drug absorption profile. A high-fat meal can increase Ivermectin bioavailability, but the resulting variability in absorption is generally considered less desirable than the more controlled fasting-state pharmacokinetics for standard dosing. Always follow your physician’s explicit instructions regarding administration conditions for your specific indication.

❓ Is Covilife Tablet effective for scabies?

Yes — Covilife Ivermectin Tablet is an established, evidence-based treatment for scabies when prescribed by a physician for appropriate indications. It is particularly valuable for crusted (Norwegian) scabies, where the hyperinfestation of millions of mites requires systemic treatment beyond what topical agents alone can achieve. It is also used for widespread classical scabies, cases of topical treatment failure, and institutional outbreak management. A repeat dose one to two weeks after the initial treatment is commonly prescribed to ensure elimination of newly hatched mites. Simultaneous treatment of all close contacts is essential to prevent re-infestation.

❓ Can children take Covilife Tablet?

Ivermectin is generally appropriate for children weighing 15 kg (33 lbs) or more at standard weight-based therapeutic doses. However, the 24mg and 40mg strength formulations in Covilife are specifically designed for adult weight ranges. For pediatric patients, lower-strength Ivermectin formulations are typically more appropriate to allow accurate dose calculation and administration. Covilife’s higher-strength tablets should only be used in children under explicit specialist prescription with confirmed weight-appropriate dose calculation. Children below 15 kg should not receive any Ivermectin formulation without specialist authorization.

❓ Does Covilife Tablet cause side effects?

Most patients taking Covilife Ivermectin Tablet at the correct prescribed therapeutic dose experience mild and temporary side effects or none at all. Commonly reported effects include brief dizziness, headache, nausea, or fatigue — typically resolving within one to two days. Patients with onchocerciasis or filarial infections may additionally experience a Mazzotti reaction — a transient immune-mediated inflammatory response to dying microfilariae that can include fever, itching, and joint pain, confirming that the treatment is working. Serious adverse events are rare at approved therapeutic doses but require immediate medical attention if they occur.

❓ Is a prescription required for Covilife Tablet?

Yes — Covilife Tablet, particularly in the 24mg and 40mg strengths, requires a valid prescription from a licensed physician in most jurisdictions. Prescription-only status exists to ensure that Ivermectin is used for properly diagnosed parasitic conditions, at the correct individualized weight-based dose, with appropriate monitoring for adverse effects and treatment response. The higher strengths available in Covilife make physician oversight even more important to ensure dosing accuracy and patient safety. Always comply with your country’s healthcare regulations and obtain a formal medical diagnosis and prescription before purchasing or taking Covilife Tablet.

❓ Can parasitic infections return after Covilife treatment?

Re-infection or relapse is possible after successful Covilife treatment, depending on the type of infection and ongoing exposure risk. Scabies can recur through contact with untreated infected individuals or through re-exposure to contaminated items — making simultaneous treatment of all household contacts and thorough laundering of textiles and bedding essential. Strongyloidiasis may relapse if the autoinfection cycle is not fully interrupted, particularly in immunocompromised patients requiring extended treatment protocols. Onchocerciasis requires ongoing annual or semi-annual Ivermectin therapy because the drug eliminates microfilariae but does not kill adult worms, which continue producing new larvae for the remainder of their lifespan (up to 15 years).

❓ Can I buy Covilife Tablet online?

Covilife Tablet can be purchased online through licensed and properly regulated online pharmacy platforms that comply with applicable national pharmaceutical laws and prescription requirements. When purchasing any prescription antiparasitic medicine online, it is essential to:

Verify the pharmacy holds a valid pharmaceutical retail license from the appropriate regulatory authority
Confirm that medicines are sourced from licensed manufacturers and authorized distributors
Ensure the platform requires a valid prescription where legally mandated
Use secure, encrypted payment and personal data protection
Check for transparent customer support, returns policy, and contact information

Avoid all unlicensed, unverified, or grey-market online sellers — counterfeit or substandard antiparasitic medicines pose severe and potentially life-threatening health risks.

❓ How should I store Covilife Tablets?

Store Covilife Tablets at room temperature below 30°C (86°F), away from direct sunlight, moisture, and heat. Keep tablets in the original sealed packaging with the closure secured. Store completely out of reach of children and pets. Check the printed expiry date before use — never take expired tablets. Dispose of unused medicines responsibly through pharmaceutical take-back programs — do not discard in household waste or flush down drains.

❓ Are the 24mg and 40mg strengths of Covilife the same as standard Ivermectin tablets?

Yes — Covilife 24mg and 40mg Tablets contain the same active ingredient (Ivermectin) as standard lower-strength formulations (3mg, 6mg, 12mg), and the mechanism of action, approved indications, precautions, and safety profile are identical. The difference lies purely in the milligram strength per tablet, which allows adult patients to receive their full prescribed weight-based dose in fewer tablets, improving convenience and dosing accuracy. Your physician will specify the appropriate strength and number of tablets based on your body weight and diagnosed condition.

Why Buy Covilife Tablet Online?

For patients who have received a valid prescription for Covilife Ivermectin Tablet, purchasing through a licensed online pharmacy platform offers a range of meaningful practical advantages:

🏠 Complete Convenience — Access at Any Hour

Licensed online pharmacy platforms operate 24 hours a day, 7 days a week, throughout the year — including public holidays and outside normal business hours when local pharmacies are unavailable. For patients managing physician-prescribed antiparasitic treatment, the ability to order promptly at any time ensures there are no avoidable delays in accessing your prescribed medication.

✅ Guaranteed Genuine, Regulatory-Compliant Medicines

Reputable, licensed online pharmacies maintain rigorous pharmaceutical supply chain integrity, sourcing all medicines — including Covilife Tablet — exclusively from verified licensed manufacturers and authorized pharmaceutical distributors. This guarantees every tablet is genuine, properly stored from manufacturer to delivery, correctly labeled, and within its validated shelf life — providing complete confidence in the safety and quality of your treatment.

🔒 Fully Secured and Confidential Ordering

Every transaction on a trusted online pharmacy platform is protected by advanced SSL encryption and PCI-DSS compliant payment security, ensuring your personal information, medical details, and financial data remain completely private throughout every stage of your purchasing experience. Reputable platforms treat your health information with the highest standards of confidentiality and data protection.

💰 Competitive Pricing with Transparent Savings

Licensed online pharmacies consistently offer more competitive pricing than traditional retail pharmacies, with lower operational overheads allowing real savings to be passed on to customers. Many platforms additionally provide loyalty programs, repeat prescription discounts, seasonal promotions, and new customer offers — making clinically necessary prescription antiparasitic treatment more financially accessible without any compromise in medicine quality or authenticity.

🚚 Fast, Reliable, and Discreet Home Delivery

Your Covilife Tablet order is dispatched in discreet, tamper-evident packaging that protects medicine integrity throughout transit while preserving your privacy. Leading online pharmacy platforms offer flexible delivery options — from standard scheduled delivery to express and next-day services — ensuring your prescription medicine reaches you when and where you need it, without disruption to your treatment schedule.

📋 Access to Professional Pharmaceutical Support

Quality online pharmacy platforms also provide patients with access to medically reviewed medicine information, downloadable patient information leaflets, and online pharmacist support services — ensuring you have the professional guidance and accurate information needed to use your prescribed medicine safely and effectively.

Conclusion

Covilife Tablet (Ivermectin 24mg / 40mg) represents a high-strength formulation of one of the most scientifically significant, globally impactful, and clinically proven antiparasitic medicines in the history of human healthcare. The Nobel Prize-recognized discovery of Ivermectin, its inclusion on the WHO Model List of Essential Medicines, and its transformative role in the international control of onchocerciasis and lymphatic filariasis across entire world regions — these achievements speak to the extraordinary depth of scientific evidence and global clinical confidence that underpins every Covilife Tablet.

For individual patients, Covilife Ivermectin Tablet provides targeted, evidence-based treatment for strongyloidiasis, onchocerciasis, scabies, head lice, and other susceptible parasitic infections — delivering potent antiparasitic action through a mechanism that selectively targets invertebrate parasites while preserving human cellular safety at therapeutic doses. The 24mg and 40mg strengths available in Covilife address the precise clinical need for accurate, weight-appropriate high-dose administration in adult patients under physician supervision.

It is essential, however, to reaffirm the fundamental principle that governs all appropriate use of Covilife Tablet: this medicine must only be used for clinically diagnosed, evidence-based antiparasitic indications as prescribed by a qualified and licensed healthcare professional. All dosing is weight-based and indication-specific. Self-medication, use for unconfirmed conditions, and any application beyond established approved indications are not appropriate and may be harmful.

For patients with confirmed parasitic infections requiring physician-prescribed Ivermectin therapy, Covilife Tablet delivers the clinical efficacy, dosing precision, and treatment reliability that effective antiparasitic management demands.

🛒 Ready to buy Covilife Tablet online? Shop through our verified, licensed pharmacy platform with confidence — genuine medicines, prescription verification, secure checkout, and fast discreet home delivery, every order.

⚠️ Medical and Legal Disclaimer: All content on this page is provided solely for general educational and informational purposes and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Covilife Tablet (Ivermectin) is a prescription medicine in most jurisdictions. Its use must be based on proper medical evaluation, confirmed diagnosis of a susceptible parasitic infection, and physician-prescribed weight-based dosing. This page does not promote, support, or endorse the use of Ivermectin for any condition beyond its established, regulatory-approved antiparasitic indications. Always consult a qualified licensed healthcare professional before starting, modifying, or discontinuing any prescription medication.

Content developed by certified pharmaceutical content specialists with reference to WHO Essential Medicines guidelines, Nobel Committee documentation of Ivermectin’s discovery, established avermectin pharmacology, current antiparasitic clinical treatment standards, and peer-reviewed parasitology literature. Reviewed for medical accuracy, EEAT compliance, regulatory responsibility, and comprehensive SEO optimization.

Active-Ingredient	Ivermectin
Manufacturers	Kachhela Medex Private Limited
Packaging	10 Tablets in a strip
Strength	24mg, 40mg
Delivery-Time	15 to 17 days

mg:	24Mg 40Mg
unit:	100 Tablets 200 Tablets 300 Tablets Clear

Covilife (Ivermectin)